US Stock Futures Edge Higher Ahead Of Productivity Data

Pre-open moversUS stock futures traded slightly higher in early pre-market trade. Data on nonfarm business productivity for the second quarter will be released at 8:30 a.m. ET, while wholesale trade data for June will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average gained 7 points to 16,328.00, while the Standard & Poor's 500 index futures rose 2.10 points to 1,907.30. Futures for the Nasdaq 100 index gained 1.25 points to 3,858.00.A Peek Into Global Markets European markets were mostly lower today, with the Spanish Ibex Index gaining 0.35%, STOXX Europe 600 Index declining 0.83%. German DAX 30 index fell 0.76%, French CAC 40 Index tumbled 0.26% and London's FTSE 100 Index dropped 0.58%. German imports rose by 4.5% in June versus May, while exports climbed 0.9% in June. French industrial production jumped 1.3% in June versus May.In Asian markets, Japan's Nikkei Stock Average tumbled 2.98%, Hong Kong's Hang Seng Index dropped 0.23%, China's Shanghai Composite Index gained 0.31% and India's Sensex fell 1.02%. China's exports surged 14.5% y/y in July, while imports dropped 1.6%.Broker RecommendationAnalysts at RBC Capital downgraded Mylan (NASDAQ: MYL) from Outperform to Sector Perform. The target price for Mylan has been lowered from $60.00 to $53.00.Mylan's shares declined 1.44% to $45.82 in pre-market trading. Breaking news

• Magna International (NYSE: MGA) reported stronger-than-expected second-quarter profit and lifted its full-year sales outlook. To read the full news, click here.
• CBS (NYSE: CBS) second-quarter net earnings from continuing operations fell nearly four percent and the company doubled its stock buyback authorization to $6 billion. To read the full news, click here.
• Zynga (NASDAQ: ZNGA) on Thursday posted some disappointing figures on its second quarter earnings report. To read the full news, click here.
• Tekmira Pharmaceuticals (NASDAQ: TKMR) shares jumped 15.5% in pre-market trading when the company said a Food and Drug Administration action may enable the use of the company's TKM-Ebola drug for individuals infected with Ebola virus. To read the full news, click here.